Innovative Diagnostic Tech CoreMap is developing advanced, patient-specific diagnostic technologies for atrial fibrillation, presenting opportunities to collaborate on tailored medical solutions and expand market reach within electrophysiology.

Strong Investment Backing Benefiting from recent $23M total funding rounds, including Series A and B investments, CoreMap is positioned for rapid growth and product development, making it an attractive partner for suppliers and service providers supporting medical innovation.

Growing Market Focus With a targeted focus on the 33 million atrial fibrillation patients, there is substantial potential to offer complementary products, training, and support services to healthcare providers seeking specialized diagnostic tools.

Emerging Startup Potential As a relatively small company with an expanding footprint in medical device manufacturing, CoreMap offers opportunities for strategic partnerships, pilot programs, and early adoption initiatives for companies seeking to penetrate innovative cardiology markets.

Tech-Driven Solutions Utilizing a robust technology stack and digital marketing tools, CoreMap is poised to expand its outreach efficiently, creating opportunities for sales in medical equipment, software integrations, and digital health platforms aligned with their growth trajectory.